FDA product code SBY: High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids

SBY is the FDA product code for high throughput sequencing based tumor profiling test of circulating cell-free nucleic acids. It is a Class II device, regulated under 21 CFR 866.6085 and reviewed by the Pathology panel. FDA has cleared 1 510(k) submission under SBY, 1 in the last five years. The average 510(k) review took 216 days (median 216); 216 days on average over the last three years. 1 De Novo request was granted under it.

Definition

A high throughput sequencing based tumor profiling test of circulating cell-free nucleic acids is a qualitative in vitro diagnostic test intended for next generation sequencing analysis of circulating cell-free nucleic acids from plasma samples collected from peripheral whole blood to detect mutations in a panel of targeted genes to aid in the management of previously diagnosed cancer patients by qualified health care professionals. The results of the test are not prescriptive or conclusive for use of any specific therapeutic product.

Classification

FieldValue
Device nameHigh Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids
Device classClass II
Regulation21 CFR 866.6085
Review panelPA — Pathology
Medical specialtyPathology
Premarket route510(k)

510(k) clearances per year for SBY

YearClearancesAvg. review days
20261216

Compare with all 510(k) review times · Search every SBY clearance

Top SBY applicants

ApplicantClearancesLatest
Life Technologies Corporation12026-10-15

Most recent SBY clearances

510(k)ApplicantDeviceDecision dateReview days
K260827Life Technologies CorporationOncomine ™ Dx Express Test2026-10-15216

Recalls for SBY devices

FDA recall records list no recalls for product code SBY.

Frequently asked questions

What is FDA product code SBY?

SBY is the FDA product code for high throughput sequencing based tumor profiling test of circulating cell-free nucleic acids. It is a Class II device, regulated under 21 CFR 866.6085 and reviewed by the Pathology panel.

What device class is SBY?

Class II, regulation 21 CFR 866.6085. Typical premarket route: 510(k).

How long does a 510(k) take for product code SBY?

Across 1 cleared submissions the average was 216 days from receipt to decision (median 216).

Which companies have the most SBY clearances?

Life Technologies Corporation (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times